177.56
-7.33(-3.96%)
Currency In USD
| Previous Close | 184.89 |
| Open | 181.22 |
| Day High | 182.58 |
| Day Low | 177.56 |
| 52-Week High | 212.19 |
| 52-Week Low | 86.62 |
| Volume | 222.82M |
| Average Volume | 171.73M |
| Market Cap | 4.32T |
| PE | 43.84 |
| EPS | 4.05 |
| Moving Average 50 Days | 185.6 |
| Moving Average 200 Days | 174.69 |
| Change | -7.33 |
If you invested $1000 in NVIDIA Corporation (NVDA) 10 years ago, it would be worth $240,757.86 as of February 27, 2026 at a share price of $184.89. Whereas If you bought $1000 worth of NVIDIA Corporation (NVDA) shares 4 years ago, it would be worth $13,388.12 as of February 27, 2026 at a share price of $184.89.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Meta Builds AI Infrastructure With NVIDIA
GlobeNewswire Inc.
Feb 17, 2026 9:15 PM GMT
Meta’s AI Roadmap Supported by Large-Scale Deployment of NVIDIA CPUs, Networking and Millions of NVIDIA Blackwell and Rubin GPUs Meta and NVIDIA NVIDIA today announced a multiyear, multigenerational strategic partnership with Meta spanning on-premi
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI
GlobeNewswire Inc.
Jan 12, 2026 3:00 PM GMT
Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research NVIDIA and Lilly NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most
NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery
GlobeNewswire Inc.
Jan 12, 2026 3:00 PM GMT
NVIDIA BioNeMo NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery. News Summary: Lilly and NVIDIA launch